New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol

Ítems similars

• New aspects of pharmacotherapy for rheumatoid arthritis: small molecule inhibitors
  per: Evgeny Lvovich Nasonov, et al.
  Publicat: (2012-04-01)
• PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
  per: Evgeni Lvovich Nasonov
  Publicat: (2009-12-01)
• Combination therapy for rheumatoid arthritis with rituximab and leflunomide(preliminary results of the Russian ARBITR Registry)
  per: Evgeniy L'vovich Nasonov, et al.
  Publicat: (2011-02-01)
• Certolizumab pegol in therapy for rheumatoid arthritis
  per: Galina Viktorovna Lukina, et al.
  Publicat: (2012-06-01)
• Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
  per: Barnes, Theresa, et al.
  Publicat: (2007)